Short answer
No cannabis product is FDA-approved to treat autism. The FDA has approved one CBD medicine, Epidiolex, and only for three seizure disorders. Evidence for autism comes from small trials, case reports, and surveys. Most reviews rate that evidence as low quality. THC-dominant products add risk for children and teens.
What the FDA has approved
Epidiolex (cannabidiol) won approval in 2018 for seizures in Lennox-Gastaut syndrome and Dravet syndrome. Approval expanded in 2020 to tuberous sclerosis complex. Autism is not on the label. Cannabis given for autism in the US is off-label or, in many cases, outside federal law. Some states list autism as a qualifying condition for their medical cannabis programs. State lists differ. Check the current list for your state.
What trials show
The largest randomized trial of cannabis for autism ran in Israel. Researchers gave 150 children and teens either a CBD-rich extract or a placebo for 12 weeks. About 49 percent of the CBD group showed clinician-rated improvement, compared with 15 percent of the placebo group. Groups differed on some measures, not all. The sample was small. Earlier work used open-label designs with no placebo. Reviews published in 2022 and 2023 concluded that evidence is not sufficient to recommend cannabinoids for autism.
Cannabis for Autism Side Effects: What to Watch For
Product forms and convenience
Caregivers pick gummies, tinctures, and capsules because dosing is simple and delivery is fast. Convenience does not equal consistency. A 2017 JAMA analysis of 84 CBD products sold online found fewer than one third matched their label. Some bottles held THC. In children, THC can cause drowsiness and mood change. Heavy teen use is linked to a higher risk of psychosis. CBD also interacts with drugs. It raises blood levels of clobazam and can affect valproate and other medicines broken down by CYP enzymes.
cannabis for autism side effects
Regulation and testing
Federal law treats cannabis with more than 0.3 percent THC as a Schedule I drug. Hemp-derived CBD is legal under the 2018 Farm Bill, but the FDA has not set rules for CBD in food or supplements. State medical programs set their own testing, label, and dose limits. Ask for a certificate of analysis. It lists cannabinoid content and contaminant tests. Check the batch number on that document against the package.
Questions for a clinician
- Does my child take a drug that CBD interacts with, such as clobazam or valproate?
- What dose and form were used in the trials you cite?
- How will we track behavior, sleep, and seizures?
- What side effects should stop use and trigger a call?
Bottom line
Evidence for cannabis in autism is early. One randomized trial and several small studies show signals. No product is approved. Convenience features, such as gummies and delivery, do not change the evidence or the interaction risks. Talk to a clinician who treats autism before starting anything.